{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:32:35Z","timestamp":1772119955020,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12020-021-02718-w","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T14:03:47Z","timestamp":1618495427000},"page":"65-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Sodium glucose cotransporter 2 inhibitors treatment in acromegalic patients with diabetes\u2014a case series and literature review"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7482-3104","authenticated-orcid":false,"given":"Adnan","family":"Zaina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuval","family":"Grober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Abid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eldad","family":"Arad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Golden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samih","family":"Badarny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"2718_CR1","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"L. Katznelson, E.R. Laws, S. Melmed et al. Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99, 3933\u20133951 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2718_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/er.2018-00115","volume":"40","author":"MR Gadelha","year":"2019","unstructured":"M.R. Gadelha, L. Kasuki, D.S.T. Lim, M. Fleseriu, Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr. Rev. 40, 268\u2013332 (2019)","journal-title":"Endocr. Rev."},{"key":"2718_CR3","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"B. Zinman, C. Wanner, J.M. Lachin,EMPA-REG OUTCOME Investigators et al., Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373, 2117\u20132128 (2015)","journal-title":"N. Engl. J. Med."},{"key":"2718_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/ejhf.1432","volume":"21","author":"JJV McMurray","year":"2019","unstructured":"J.J.V. McMurray, D.L. DeMets, S.E. Inzucchi, L. K\u00f8ber, M.N. Kosiborod, A.M. Langkilde, F.A. Martinez, O. Bengtsson, P. Ponikowski, M.S. Sabatine, M. Sj\u00f6strand, S.D. Solomon,DAPA-HF Committees and Investigators, A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). Eur. J. Heart Fail. 21, 665\u2013675 (2019)","journal-title":"Eur. J. Heart Fail."},{"key":"2718_CR5","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1681\/ASN.2018010103","volume":"29","author":"C Wanner","year":"2018","unstructured":"C. Wanner, H.J.L. Heerspink, B. Zinman, S.E. Inzucchi, A. Koitka-Weber, M. Mattheus, S. Hantel, H.J. Woerle, U.C. Broedl, M. von Eynatten, P.H. Groop,EMPA-REG OUTCOME Investigators, Empagliflozin and kidney function decline in patients with type 2 diabetes: a slope analysis from the EMPA-REG OUTCOME trial. J. Am. Soc. Nephrol. 29, 2755\u20132769 (2018)","journal-title":"J. Am. Soc. Nephrol."},{"key":"2718_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.tem.2016.04.014","volume":"27","author":"S Frara","year":"2016","unstructured":"S. Frara, F. Maffezzoni, G. Mazziotti, A. Giustina, Current and emerging aspects of diabetes mellitus in acromegaly. Trends Endocrinol. Metab. 27, 470\u2013483 (2016)","journal-title":"Trends Endocrinol. Metab."},{"key":"2718_CR7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1210\/jc.2017-00082","volume":"102","author":"M Quarella","year":"2017","unstructured":"M. Quarella, D. Walser, M. Br\u00e4ndle, J.Y. Fournier, S. Bilz, Rapid onset of diabetic ketoacidosis after SGLT2 inhibition in a patient with unrecognized acromegaly. J. Clin. Endocrinol. Metab. 102, 1451\u20131453 (2017)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2718_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.metabol.2015.12.007","volume":"65","author":"EA Nyenwe","year":"2016","unstructured":"E.A. Nyenwe, A.E. Kitabchi, The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis and management. Metabolism 65, 507\u2013521 (2016)","journal-title":"Metabolism"},{"key":"2718_CR9","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.2337\/dc15-1380","volume":"38","author":"J Rosenstock","year":"2015","unstructured":"J. Rosenstock, E. Ferrannini, Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Diabetes Care 38, 1638\u20131642 (2015)","journal-title":"Diabetes Care"},{"key":"2718_CR10","doi-asserted-by":"publisher","first-page":"105 dgaa200","DOI":"10.1210\/clinem\/dgaa200","volume":"1","author":"N Fleming","year":"2020","unstructured":"N. Fleming, P.S. Hamblin, D. Story, E.I. Ekinci, Evolving evidence of diabetic ketoacidosis in patients taking sodium-glucose cotransporter 2 inhibitors. J. Clin. Endocrinol. Metab. 1, 105 dgaa200 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa200","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2718_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1172\/JCI72227","volume":"124","author":"E Ferrannini","year":"2014","unstructured":"E. Ferrannini, E. Muscelli, S. Frascerra et al. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J. Clin. Invest 124, 499\u2013508 (2014)","journal-title":"J. Clin. Invest"},{"key":"2718_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.diabet.2018.06.005","volume":"44","author":"C Saponaro","year":"2018","unstructured":"C. Saponaro, F. Pattou, C. Bonner, SGLT2 inhibition and glucagon secretion in humans. Diabetes Metab. 44, 383\u2013385 (2018)","journal-title":"Diabetes Metab."},{"key":"2718_CR13","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1210\/jc.2008-2332","volume":"94","author":"G Mazziotti","year":"2009","unstructured":"G. Mazziotti, I. Floriani, S. Bonadonna, V. Torri, P. Chanson, A. Giustina, Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. J. Clin. Endocrinol. Metab. 94, 1500\u20131508 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2718_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1210\/jc.2013-2480","volume":"99","author":"A Colao","year":"2014","unstructured":"A. Colao, M.D. Bronstein, P. Freda, F. Gu, C.C. Shen, M. Gadelha, M. Fleseriu, A.J. van der Lely, A.J. Farrall, K. Hermosillo Res\u00e9ndiz, M. Ruffin, Y. Chen, M. Sheppard, P.C.S. Group, Pasireotide versus octreotide in acromegaly: a head-to-head superiority study. J. Clin. Endocrinol. Metab. 99, 791\u2013799 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2718_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1530\/eje.0.1490521","volume":"149","author":"WM Drake","year":"2003","unstructured":"W.M. Drake, S.V. Rowles, M.E. Roberts, F.K. Fode, G.M. Besser, J.P. Monson, P.J. Trainer, Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant. Eur. J. Endocrinol. 149, 521\u2013527 (2003)","journal-title":"Eur. J. Endocrinol."},{"key":"2718_CR16","doi-asserted-by":"publisher","unstructured":"Fleseriu, M., Biller, B.M.K., Freda, P.U., Gadelha, M.R., Giustina, A., Katznelson, L., Molitch, M.E., Samson, S.L., Strasburger, C.J., van der Lely, A.J., Melmed, S. A Pituitary Society update to acromegaly management guidelines. (2020) https:\/\/doi.org\/10.1007\/s11102-020-01091-7","DOI":"10.1007\/s11102-020-01091-7"},{"key":"2718_CR17","first-page":"131","volume":"78","author":"P Ocampo","year":"2018","unstructured":"P. Ocampo, J.M. Duarte, R. Barcia, C. Ar\u00e9valo, Association between diabetic ketoacidosis and acromegaly. Medicine 78, 131\u2013133 (2018)","journal-title":"Medicine"},{"key":"2718_CR18","doi-asserted-by":"publisher","first-page":"2390797","DOI":"10.1155\/2017\/2390797","volume":"2017","author":"A Herrero-Ruiz","year":"2017","unstructured":"A. Herrero-Ruiz, H.S. Villanueva-Alvarado, J.J. Corrales-Hern\u00e1ndez, C. Higueruela-M\u00ednguez, J. Feito-P\u00e9rez et al. Coexistence of GH-producing pituitary macroadenoma and meningioma in a patient with multiple endocrine neoplasia type 1 with hyperglycemia and ketosis as first clinical sign. Case Rep. Endocrinol. 2017, 2390797 (2017). https:\/\/doi.org\/10.1155\/2017\/2390797","journal-title":"Case Rep. Endocrinol."},{"key":"2718_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.diabres.2017.08.023","volume":"134","author":"J Weiss","year":"2017","unstructured":"J. Weiss, A.J. Wood, J.D. Zajac, M. Grossmann, S. Andrikopoulos, E.I. Ekinci, Diabetic ketoacidosis in acromegaly; a rare complication precipitated by corticosteroid use. Diabetes Res. Clin. Pract. 134, 29\u201337 (2017)","journal-title":"Diabetes Res. Clin. Pract."},{"key":"2718_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s13340-016-0301-z","volume":"10","author":"H Inaba","year":"2017","unstructured":"H. Inaba, T. Funahashi, H. Ariyasu et al. Diabetic ketoacidosis in a patient with acromegaly and central diabetes insipidus treated with octreotide long-acting release. Diabetol. Int 10, 237\u2013242 (2017)","journal-title":"Diabetol. Int"},{"key":"2718_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/EJE-13-0060","volume":"169","author":"N Yoshida","year":"2013","unstructured":"N. Yoshida, H. Goto, H. Suzuki, K. Nagasawa, A. Takeshita et al. Ketoacidosis as the initial clinical condition in nine patients with acromegaly: a review of 860 cases at a single institute. Eur. J. Endocrinol. 169, 127\u2013132 (2013)","journal-title":"Eur. J. Endocrinol."},{"key":"2718_CR22","doi-asserted-by":"crossref","first-page":"bcr2013010198","DOI":"10.1136\/bcr-2013-010198","volume":"11","author":"RV Dosi","year":"2013","unstructured":"R.V. Dosi, R.D. Patell, P.J. Shah et al. Diabetic ketoacidosis: an unusual presentation of acromegaly. BMJ Case Rep. 11, bcr2013010198 (2013)","journal-title":"BMJ Case Rep."},{"key":"2718_CR23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.kjms.2013.08.002","volume":"29","author":"HJ Jiang","year":"2013","unstructured":"H.J. Jiang, W.W. Hung, P.J. Hsiao, A case of acromegaly complicated with diabetic ketoacidosis, pituitary apoplexy, and lymphoma. Kaohsiung J. Med Sci. 29, 687\u2013690 (2013)","journal-title":"Kaohsiung J. Med Sci."},{"key":"2718_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP12189.CR","volume":"27","author":"P Palakawong","year":"2012","unstructured":"P. Palakawong, R. Arakaki, Diabetic ketoacidosis in acromegaly: a case report. Endocr. Pract. 27, 1\u201315 (2012)","journal-title":"Endocr. Pract."},{"key":"2718_CR25","first-page":"405","volume":"75","author":"P Mewawalla","year":"2011","unstructured":"P. Mewawalla, G. Jaiswal, M. Moustakakis et al. Refractory DKA as first presentation of acromegaly and a potential role for continuous venovenous hemofiltration in its successful management. Conn. Med. 75, 405\u2013407 (2011)","journal-title":"Conn. Med."},{"key":"2718_CR26","first-page":"2008.1226","volume":"11","author":"M Waterhouse","year":"2009","unstructured":"M. Waterhouse, I. Sabin, N. Plowman, S. Akker, T.A. Chowdhury, A \u201cgrowing cause\u201d of diabetic ketoacidosis. BMJ Case Rep. 11, 2008.1226 (2009)","journal-title":"BMJ Case Rep."},{"key":"2718_CR27","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0929-6646(08)60042-X","volume":"106","author":"YL Chen","year":"2007","unstructured":"Y.L. Chen, C.P. Wei, C.C. Lee et al. Diabetic ketoacidosis in a patient with acromegaly. J. Formos. Med. Assoc. 106, 788\u2013791 (2007)","journal-title":"J. Formos. Med. Assoc."},{"key":"2718_CR28","first-page":"377","volume":"55","author":"M Lakhotia","year":"2007","unstructured":"M. Lakhotia, R. Mathur, H. Singh et al. Diabetic ketosis as a presenting feature of acromegaly. J. Assoc. Physicians India 55, 377\u2013378 (2007)","journal-title":"J. Assoc. Physicians India"},{"key":"2718_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1385\/ENDO:30:1:145","volume":"30","author":"C Erem","year":"2006","unstructured":"C. Erem, H.O. Ers\u00f6z, K. Ukin\u00e7 et al. Acromegaly presenting with diabetic ketoacidosis, associated with retinitis pigmentosa and octreotide-induced bradycardia: a case report and a review of the literature. Endocrine 30, 145\u2013149 (2006)","journal-title":"Endocrine"},{"key":"2718_CR30","first-page":"142","volume":"7","author":"B Kopff","year":"2001","unstructured":"B. Kopff, S. Mucha, B.H. Wolffenbuttel et al. Diabetic ketoacidosis in a patient with acromegaly. Med. Sci. Monit. 7, 142\u2013147 (2001)","journal-title":"Med. Sci. Monit."},{"key":"2718_CR31","first-page":"450","volume":"6","author":"SA Westphal","year":"2000","unstructured":"S.A. Westphal, Concurrent diagnosis of acromegaly and diabetic ketoacidosis. Endocr. Pract. 6, 450\u2013452 (2000)","journal-title":"Endocr. Pract."},{"key":"2718_CR32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1742-1241.1997.tb11523.x","volume":"51","author":"CC Szeto","year":"1997","unstructured":"C.C. Szeto, K.Y. Li, G.T. Ko et al. Acromegaly in a woman presenting with diabetic ketoacidosis and insulin resistance. Int. J. Clin. Pract. 51, 476\u2013477 (1997)","journal-title":"Int. J. Clin. Pract."},{"key":"2718_CR33","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/pgmj.72.853.682","volume":"72","author":"JR Katz","year":"1996","unstructured":"J.R. Katz, R. Edwards, M. Khan, G.S. Conway, Acromegaly presenting with diabetic ketoacidosis. Postgrad. Med. J. 72, 682\u2013683 (1996)","journal-title":"Postgrad. Med. J."},{"key":"2718_CR34","first-page":"76","volume":"12","author":"J Vidal Cortada","year":"1995","unstructured":"J. Vidal Cortada, J.I. Conget Donlo, M.P. Navarro T\u00e9llez, I. Halperin Rabinovic, E. Vilardell Latorre, Diabetic ketoacidosis as the first manifestation of acromegaly. An. Med. Interna 12, 76\u201378 (1995)","journal-title":"An. Med. Interna"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02718-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02718-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02718-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T08:45:43Z","timestamp":1724834743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02718-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2718"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02718-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-156859\/v1","asserted-by":"object"}]},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]},"assertion":[{"value":"15 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}